Clinical Trial Update: Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus [Phase 1, Phase 2]

View source ↗

Summary

Glaukos Corporation is conducting a Phase 1/2 clinical trial to evaluate the safety and efficacy of corneal cross-linking for progressive keratoconus, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: Glaukos Corporation | Conditions: Progressive Keratoconus | Phase 1, Phase 2 | Status: RECRUITING